Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1,156,685
-
Shares change
-
-18,728
-
Total reported value, excl. options
-
$4,591,000
-
Value change
-
-$184,271
-
Number of buys
-
4
-
Number of sells
-
-8
-
Price
-
$3.97
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q2 2021
19 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q2 2021.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,156,685 shares
of 66,587,586 outstanding shares and own 1.74% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (633,944 shares), VANGUARD GROUP INC (167,378 shares), RENAISSANCE TECHNOLOGIES LLC (116,696 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (113,400 shares), EDGEWOOD MANAGEMENT LLC (50,000 shares), SYNOVUS FINANCIAL CORP (23,060 shares), SeaCrest Wealth Management, LLC (13,500 shares), CITADEL ADVISORS LLC (10,873 shares), GEODE CAPITAL MANAGEMENT, LLC (10,188 shares), and MILLENNIUM MANAGEMENT LLC (10,055 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.